Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIPPS trial of prophylactic dalteparin in high-risk pregnant women with thrombophilia
2007-000284-21Phase 3Completed
- Sponsor
- York and Scarborough Teaching Hospitals NHS Foundation Trust
- Start
- Jul 2007
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of dalteparin in Hypercoagulability and venous thromboembolism (VTE) (2 arms), sponsored by York and Scarborough Teaching Hospitals NHS Foundation Trust. Primary endpoints: Primary composite endpoint, Objectively documented venous thromboembolism and 3 more. Started Jul 2007; status: completed.
02
Drugs
dalteparin
03
Conditions
Hypercoagulabilityvenous thromboembolism (VTE)
Beyond the preview
Go deeper on 2007-000284-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000284-21.